{"id":"73acde35-0719-494d-99db-82f62d2ddaac","kind":"companies","code":"UB-C6823","name":"BioMind","nameBasis":"source-english","summary":"BioMind is a company headquartered in Beijing, China.","description":"","country":"China","category":null,"originalName":"安德医智","eventDate":null,"website":"https://www.biomind.cn/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-15T17:10:20.176Z","reviewedAt":"2026-10-15T17:10:20.176Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"38cc9826415fa9444432a9303b4ff0c85850e8244a69f4d618e399d5bed034bc","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"64651171-956d-4713-89d6-4de3efc057b2","kind":"news","code":"64651171-956d-4713-89d6-4de3efc057b2","name":"BioMind completes strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"安德医智完成战略投资融资","eventDate":"2025-03-21T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:40:28.239Z","englishUpdatedAt":"2026-10-15T17:19:59.582Z","reviewedAt":"2026-10-15T17:19:59.582Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"4734cb36294f336b65ff6dc83dbf777695f8dfb4258c85cf12477e0319b6d655","companyId":"73acde35-0719-494d-99db-82f62d2ddaac","foundedYear":null,"logoUrl":null,"path":"/news/64651171-956d-4713-89d6-4de3efc057b2"},{"id":"32039561-5afa-482d-b7f3-7690482391ae","kind":"institutions","code":"UB-I260","name":"国科投资","nameBasis":"transliterated","summary":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","description":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","country":null,"category":null,"originalName":"国科投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.809Z","englishUpdatedAt":"2026-10-15T21:21:01.625Z","reviewedAt":"2026-10-15T21:21:01.625Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6a6dec4b146f18dc74195f3d75739be22ccefd3fadc38321961445e4e42bfba8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guoke Investment","path":"/institutions/guoke-investment"}],"finance":{"funding":{"metric":"funding","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"64651171-956d-4713-89d6-4de3efc057b2","date":"2025-03-21T00:00:00.000Z","round":"Strategic","amountText":"未披露","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"国科投资","institutions":[{"id":"32039561-5afa-482d-b7f3-7690482391ae","kind":"institutions","code":"UB-I260","name":"国科投资","nameBasis":"transliterated","summary":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","description":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","country":null,"category":null,"originalName":"国科投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.809Z","englishUpdatedAt":"2026-10-15T21:21:01.625Z","reviewedAt":"2026-10-15T21:21:01.625Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6a6dec4b146f18dc74195f3d75739be22ccefd3fadc38321961445e4e42bfba8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guoke Investment","path":"/institutions/guoke-investment"}],"newsUrl":null,"evidence":{"headline":"BioMind completes strategic financing","brief":null,"basis":null,"newsPath":"/news/64651171-956d-4713-89d6-4de3efc057b2","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"64651171-956d-4713-89d6-4de3efc057b2","date":"2025-03-21T00:00:00.000Z","round":"Strategic","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"国科投资","institutions":[{"id":"32039561-5afa-482d-b7f3-7690482391ae","kind":"institutions","code":"UB-I260","name":"国科投资","nameBasis":"transliterated","summary":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","description":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","country":null,"category":null,"originalName":"国科投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.809Z","englishUpdatedAt":"2026-10-15T21:21:01.625Z","reviewedAt":"2026-10-15T21:21:01.625Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6a6dec4b146f18dc74195f3d75739be22ccefd3fadc38321961445e4e42bfba8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guoke Investment","path":"/institutions/guoke-investment"}],"newsUrl":null,"evidence":{"headline":"BioMind completes strategic financing","brief":null,"basis":null,"newsPath":"/news/64651171-956d-4713-89d6-4de3efc057b2","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"64651171-956d-4713-89d6-4de3efc057b2","kind":"funding","eventDate":"2025-03-21T00:00:00.000Z","revenueDate":null,"round":"战略投资","amountText":"未披露","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"国科投资","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"32039561-5afa-482d-b7f3-7690482391ae","kind":"institutions","code":"UB-I260","name":"国科投资","nameBasis":"transliterated","summary":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","description":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","country":null,"category":null,"originalName":"国科投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.809Z","englishUpdatedAt":"2026-10-15T21:21:01.625Z","reviewedAt":"2026-10-15T21:21:01.625Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6a6dec4b146f18dc74195f3d75739be22ccefd3fadc38321961445e4e42bfba8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guoke Investment","path":"/institutions/guoke-investment"}],"roundName":"Strategic","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"32039561-5afa-482d-b7f3-7690482391ae","kind":"institutions","code":"UB-I260","name":"国科投资","nameBasis":"transliterated","summary":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","description":"An investment platform within the Chinese Academy of Sciences system, investing in research commercialization and hard technology.","country":null,"category":null,"originalName":"国科投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:18:19.809Z","englishUpdatedAt":"2026-10-15T21:21:01.625Z","reviewedAt":"2026-10-15T21:21:01.625Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6a6dec4b146f18dc74195f3d75739be22ccefd3fadc38321961445e4e42bfba8","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Guoke Investment","path":"/institutions/guoke-investment"}],"path":"/companies/UB-C6823","structured":{"city":"Beijing","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"BioMind is a company headquartered in Beijing, China.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/UB-C6823"}